Tuesday, October 18, 2011

World's first malaria vaccine works in major trial

"An experimental vaccine from GlaxoSmithKline halved the risk of African children getting malaria in a major clinical trial, making it likely to become the world's first shot against the deadly disease.

Final-stage trial data released on Tuesday showed it gave protection against clinical and severe malaria in five- to 17-month-olds in Africa, where the mosquito-borne disease kills hundreds of thousands of children a year."

For more on the report, click here.

Sunovion Pharmaceuticals Inc. Announces Partnership with CARE to Help Improve the Health and Lives of Those in Need

"Sunovion Pharmaceuticals Inc. announced today, on the United Nations' International Day for the Eradication of Poverty, a partnership with CARE, a leading global humanitarian organization, to help the international agency in its mission to reduce global poverty and provide emergency aid-related services. More than 900 million people throughout the world live on less than one dollar a day. As part of Sunovion's Follow the WingsTM campaign, Sunovion will contribute $1 to CARE, up to a total of $100,000, each time the interactive game is played or shared. People are encouraged to visit www.FollowtheWings.com to play and share the game."

Click here to learn more about this campaign.